In 84 open-chest dogs, we studied the effects on early afterdepolarizations (EADs) and ventricular tachyarrhythmias (VTs) induced by cesium chloride (168 mg/kg i.v.) of α-adrenoceptor stimulation with phenylephrine (100 μg plus 0.25 μg/kg/min i.v.) and with left ansa subclavia stimulation (LAS; 2 Hz, 4 msec, 2 mA) after propranolol (0.5 mg/kg) administration. We also studied the effects of α-adrenoceptor blockade with phentolamine (3 mg/kg), prazosin (25-500 μg/kg), yohimbine (10-500 μg/kg), WB 4101 (2 mg/kg), and benoxathian (2 mg/kg) during decentralized LAS. EAD amplitude, presented as a percentage of monophasic action potential amplitude, was recorded simultaneously with contact electrodes from the right and left ventricular endocardium. Phenylephrine and LAS plus propranolol increased EAD amplitude (31.5 ± 8.8% to 47.8 ± 9.7% and 34.8 ± 4.1% to 46.1 ± 6.4%, respectively) and the prevalence of VT (from three to nine of 11 dogs and from the three to five of six dogs, respectively). Prazosin produced a dose-response decrease in EAD amplitude and reduced the prevalence of VT. Yohimbine did not alter the amplitude of EADs or the prevalence of VT. WB 4101 and phentolamine reduced the amplitude of EADs produced by cesium and LAS (from 44.3 ±10.2% to 32.6 ± 9.4% and from 39.8 ± 6.9% to 30.3 ± 6.3%, respectively) and the prevalence of VT (from eight to one of 10 dogs and from 13 to 5 of 20 dogs, respectively). Benoxathian did not alter significantly the amplitude of EADs (41.6 ± 11.4% to 37.5 ± 9.4%) or the prevalence of VT (from six to five of 10 dogs). Phentolamine without LAS did not change EAD amplitude or VT prevalence. The similar enhancing effects of phenylephrine and LAS plus propranolol and the suppressing effects of WB 4101, prazosin, and phentolamine but not yohimbine or benoxathian suggest that α-adrenoceptor stimulation increases cesium-induced EAD amplitude and VT occurrence, probably through stimulation of specific α1-adrenoceptors.
- Early afterdepolarizations
- Long QT syndrome
- Triggered activity
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine